Transgenic mice with GRK2 cardiac-specific overexpression exhibited an increase in GRK2 synthesis and activity in the heart, which led to the impairment of β-AR signaling and eventually contributed to myocardial hypertrophy [115]. This evidence concerns the gene GRK2 and cardiac hypertrophy.